Virtual Reality in Postoperative Acute Pain Management in Thoracic Surgery (VRThx)
Postoperative Pain
About this trial
This is an interventional other trial for Postoperative Pain focused on measuring thoracic surgery, Virtual reality (VR)
Eligibility Criteria
Inclusion Criteria: Patients ≥18 years Written informed consent as documented by signature from the patient Video-assisted anatomical resection of the lung (VATS) (Surgery duration of at least 90 minutes) Ability to speak, understand and read German Exclusion Criteria: Significant mental, cognitive or neurological impairments (Delirium, psychoses, unstable dissociative disorders, any form of organic brain disorder, …) Inability to follow the study procedures (e.g., due to language problems, visual and hearing impairments) Chronic pain Morphine intolerance Excessive alcohol consumption (men > 3 standard drinks, women > 2 standard drinks per day) Substance abuse Unable or not willing to sign informed consent
Sites / Locations
- University Hospital BaselRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Intervention group
Control group (standard care)
Patients receive a VR headset (Pico G2 4K) for 15 minutes in the time between the 2. and 3. pain assessment and will experience non-interactive videos with different immersive scenarios of nature scenes. Nature sounds, meditation or classical music accompanying the scenarios are played through noise-cancelling headphones. Additionally, a wearable with an optical PPG- and EDA-Sensor (Empatica EmbracePlus) is put on the wrist of each participant in both groups 15 minutes before the inhalation until 15 minutes after the third pain intensity assessment, which enables the tracking of vital signs and monitoring of physiological responses. In both groups the study procedure starts with determining the pain intensity immediately before and after the 15 minutes inhalation procedure which is part of the standard of care. 15 minutes after the second assessment, the pain intensity is determined a third time in both groups.
Patients in the control group do not receive any intervention in the time between the second and third pain assessment. Additionally, a wearable with an optical PPG- and EDA-Sensor (Empatica EmbracePlus) is put on the wrist of each participant in both groups 15 minutes before the inhalation until 15 minutes after the third pain intensity assessment, which enables the tracking of vital signs and monitoring of physiological responses. In both groups the study procedure starts with determining the pain intensity using the Numeric Rating Scale (NRS) immediately before and after the 15 minutes inhalation procedure which is part of the standard of care. 15 minutes after the second assessment, the pain intensity is determined a third time in both groups.